Showing results (1231-1240 of 5,695) with videos related to

Sort By:
Pageof 570
The Oncologist|February 8, 2024
Exploring the Landscape of Immune Checkpoint Inhibitor-Induced Adverse Events Through Big Data Mining of Pan-Cancer Clinical TrialsMuhammad Zaki Hidayatullah Fadlullah, Ching-Nung Lin, Samuel Coleman, et al.
The Oncologist|February 7, 2024
A Pilot Study of Pembrolizumab in Combination With Y90 Radioembolization in Subjects With Poor Prognosis Hepatocellular CarcinomaShawn Yu, Menggang Yu, Barry Keane, et al.
The Oncologist|February 3, 2024
The Efficacy of Immune Checkpoint Inhibitors in Microsatellite Stable Colorectal Cancer: A Systematic ReviewDeniz Can Guven, Gozde Kavgaci, Enes Erul, et al.
The Oncologist|January 11, 2024
Sequential Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-Induced Radical Surgery in Oligometastatic Non-Small Cell Lung Cancer: A Case ReportHuaiyu Wang, Zaiwen Fan, Xiaoming Yang, et al.
The Oncologist|April 6, 2024
Tumor Response Predicts Survival Time of Nivolumab Monotherapy for Advanced Gastric Cancer: A Subgroup Analysis of the DELIVER Trial (JACCRO GC-08)Yu Sunakawa, Yasuhiro Sakamoto, Ryohei Kawabata, et al.
The Oncologist|April 4, 2024
Optimal Sequential Strategies for Antibody-Drug Conjugate in Metastatic Breast Cancer: Evaluating Efficacy and Cross-ResistanceMeiting Chen, Riqing Huang, Rishang Chen, et al.
The Oncologist|March 25, 2024
Ocular Effects of MEK Inhibitor Therapy: Literature Review, Clinical Presentation, and Best Practices for MitigationKaren W Jeng-Miller, Miles A Miller, Jeffrey S Heier
The Oncologist|March 14, 2024
Statewide Cancer Drug Repository Reducing Waste in the Setting of Shortage CrisisEmily R Mackler, Siobhan Norman, Farah Jalloul
The Oncologist|March 13, 2024
Salvage Surgery for Initially Unresectable HCC With PVTT Converted by Locoregional Treatment Plus Tyrosine Kinase Inhibitor and Anti-PD-1 AntibodyLei Wang, Jin-Kai Feng, Chong-De Lu, et al.
The Oncologist|March 23, 2024
Osimertinib in Patients With Treatment-Naive EGFR-Mutant Non-small Cell Lung Cancer: Overall Survival, Post-progression Management and Budget Impact Analysis in Real-WorldGiulia Pasello, Martina Lorenzi, Daniela Scattolin, et al.
Pageof 570